| Lars Lindegren - Chief Executive Officer |
Lars Lindegren has held various senior management positions in the pharmaceutical industry
including Executive Vice President of Pharmacia AB, Chairman and CEO of Farmitalia Carlo Erba, CEO of Kabi Nutrition and CEO of Astra Pharmaceuticals International.
|
| Kjetil Taskén , Professor, M.D., Ph. D. - Vice President Research and Development |
He is together with Professor Hansson the key principal investigator who has formulated and developed the technology now owned by Lauras. He currently has the position as the Centre Director of the Biotechnology Centre, University of Oslo . Taskén has some 150 publications and patents, holds a number of excellence grants and has an outstanding scientific rating. He won the 2002 Anders Jahre’s Medical Award for Younger Scientists (Nordic Price) and has established himself as an international leader in his field. See also http://www.biotek.uio.no
|
| Liv Salvesen - Chief Financial Officer |
Holds a Master of Management degree from BI - Norwegian School of Management. She has a long experience as CFO for corporate and private companies within the sectors like Information Technology, Hospital and Health (Tandberg Data, Omnia ASA, Hewlett Packard, Norwegian Productivity Institute). For some years, she focused on turn around processes in companies hit by financial crises and on start-up companies (Henie-Onstad Kunstsenter, MedIT AS). |